ALPHA.4.BETA.2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The present invention relates to novel a4ß2 neuronal nicotinic acetylch...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KANDIKERE, NAGARAJ VISHWOTTAM MOHAMMED, ABDUL RASHEED KUMAWAT, KANA RAM JAYARAJAN, PRADEEP JASTI, VENKATESWARLU NIROGI, RAMAKRISHNA AHMAD, ISHTIYAQUE MUDIGONDA, KOTESHWARA SHINDE, ANIL KARBHARI |
| description | The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them.
La présente invention porte sur de nouveaux composés ligands du récepteur nicotinique neuronal de l'acétylcholine a4ß2 représentés par la formule (I) et sur leurs dérivés, stéréoisomères, sels pharmaceutiquement acceptables et sur des compositions les contenant. La présente invention porte également sur un procédé pour la préparation desdits nouveaux composés ci-dessus et de leurs dérivés, stéréoisomères et sels pharmaceutiquement acceptables. Les composés de formule générale (I) sont utiles dans le traitement de divers troubles liés aux récepteurs nicotiniques a4ß2. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2785957C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2785957C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2785957C3</originalsourceid><addsrcrecordid>eNrjZHBw9AnwcNQz0XNyDXHUM1Lwcw0N8vdz9FHw83T2D_EEkgqOzq4hkT7OHv4-nn6uCkGuzq4BIf5BCj6e7o5-LsE8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSTe2dHI3MLU0tTc2ZiwCgDgkymj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ALPHA.4.BETA.2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS</title><source>esp@cenet</source><creator>KANDIKERE, NAGARAJ VISHWOTTAM ; MOHAMMED, ABDUL RASHEED ; KUMAWAT, KANA RAM ; JAYARAJAN, PRADEEP ; JASTI, VENKATESWARLU ; NIROGI, RAMAKRISHNA ; AHMAD, ISHTIYAQUE ; MUDIGONDA, KOTESHWARA ; SHINDE, ANIL KARBHARI</creator><creatorcontrib>KANDIKERE, NAGARAJ VISHWOTTAM ; MOHAMMED, ABDUL RASHEED ; KUMAWAT, KANA RAM ; JAYARAJAN, PRADEEP ; JASTI, VENKATESWARLU ; NIROGI, RAMAKRISHNA ; AHMAD, ISHTIYAQUE ; MUDIGONDA, KOTESHWARA ; SHINDE, ANIL KARBHARI</creatorcontrib><description>The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them.
La présente invention porte sur de nouveaux composés ligands du récepteur nicotinique neuronal de l'acétylcholine a4ß2 représentés par la formule (I) et sur leurs dérivés, stéréoisomères, sels pharmaceutiquement acceptables et sur des compositions les contenant. La présente invention porte également sur un procédé pour la préparation desdits nouveaux composés ci-dessus et de leurs dérivés, stéréoisomères et sels pharmaceutiquement acceptables. Les composés de formule générale (I) sont utiles dans le traitement de divers troubles liés aux récepteurs nicotiniques a4ß2.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150616&DB=EPODOC&CC=CA&NR=2785957C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150616&DB=EPODOC&CC=CA&NR=2785957C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KANDIKERE, NAGARAJ VISHWOTTAM</creatorcontrib><creatorcontrib>MOHAMMED, ABDUL RASHEED</creatorcontrib><creatorcontrib>KUMAWAT, KANA RAM</creatorcontrib><creatorcontrib>JAYARAJAN, PRADEEP</creatorcontrib><creatorcontrib>JASTI, VENKATESWARLU</creatorcontrib><creatorcontrib>NIROGI, RAMAKRISHNA</creatorcontrib><creatorcontrib>AHMAD, ISHTIYAQUE</creatorcontrib><creatorcontrib>MUDIGONDA, KOTESHWARA</creatorcontrib><creatorcontrib>SHINDE, ANIL KARBHARI</creatorcontrib><title>ALPHA.4.BETA.2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS</title><description>The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them.
La présente invention porte sur de nouveaux composés ligands du récepteur nicotinique neuronal de l'acétylcholine a4ß2 représentés par la formule (I) et sur leurs dérivés, stéréoisomères, sels pharmaceutiquement acceptables et sur des compositions les contenant. La présente invention porte également sur un procédé pour la préparation desdits nouveaux composés ci-dessus et de leurs dérivés, stéréoisomères et sels pharmaceutiquement acceptables. Les composés de formule générale (I) sont utiles dans le traitement de divers troubles liés aux récepteurs nicotiniques a4ß2.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBw9AnwcNQz0XNyDXHUM1Lwcw0N8vdz9FHw83T2D_EEkgqOzq4hkT7OHv4-nn6uCkGuzq4BIf5BCj6e7o5-LsE8DKxpiTnFqbxQmptB3s01xNlDN7UgPz61uCAxOTUvtSTe2dHI3MLU0tTc2ZiwCgDgkymj</recordid><startdate>20150616</startdate><enddate>20150616</enddate><creator>KANDIKERE, NAGARAJ VISHWOTTAM</creator><creator>MOHAMMED, ABDUL RASHEED</creator><creator>KUMAWAT, KANA RAM</creator><creator>JAYARAJAN, PRADEEP</creator><creator>JASTI, VENKATESWARLU</creator><creator>NIROGI, RAMAKRISHNA</creator><creator>AHMAD, ISHTIYAQUE</creator><creator>MUDIGONDA, KOTESHWARA</creator><creator>SHINDE, ANIL KARBHARI</creator><scope>EVB</scope></search><sort><creationdate>20150616</creationdate><title>ALPHA.4.BETA.2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS</title><author>KANDIKERE, NAGARAJ VISHWOTTAM ; MOHAMMED, ABDUL RASHEED ; KUMAWAT, KANA RAM ; JAYARAJAN, PRADEEP ; JASTI, VENKATESWARLU ; NIROGI, RAMAKRISHNA ; AHMAD, ISHTIYAQUE ; MUDIGONDA, KOTESHWARA ; SHINDE, ANIL KARBHARI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2785957C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KANDIKERE, NAGARAJ VISHWOTTAM</creatorcontrib><creatorcontrib>MOHAMMED, ABDUL RASHEED</creatorcontrib><creatorcontrib>KUMAWAT, KANA RAM</creatorcontrib><creatorcontrib>JAYARAJAN, PRADEEP</creatorcontrib><creatorcontrib>JASTI, VENKATESWARLU</creatorcontrib><creatorcontrib>NIROGI, RAMAKRISHNA</creatorcontrib><creatorcontrib>AHMAD, ISHTIYAQUE</creatorcontrib><creatorcontrib>MUDIGONDA, KOTESHWARA</creatorcontrib><creatorcontrib>SHINDE, ANIL KARBHARI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KANDIKERE, NAGARAJ VISHWOTTAM</au><au>MOHAMMED, ABDUL RASHEED</au><au>KUMAWAT, KANA RAM</au><au>JAYARAJAN, PRADEEP</au><au>JASTI, VENKATESWARLU</au><au>NIROGI, RAMAKRISHNA</au><au>AHMAD, ISHTIYAQUE</au><au>MUDIGONDA, KOTESHWARA</au><au>SHINDE, ANIL KARBHARI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ALPHA.4.BETA.2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS</title><date>2015-06-16</date><risdate>2015</risdate><abstract>The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them. The present invention relates to novel a4ß2 neuronal nicotinic acetylcholine receptor ligand compounds of the formula (I), and their derivatives, stereoisomers, pharmaceutically acceptable salts and compositions containing them.
La présente invention porte sur de nouveaux composés ligands du récepteur nicotinique neuronal de l'acétylcholine a4ß2 représentés par la formule (I) et sur leurs dérivés, stéréoisomères, sels pharmaceutiquement acceptables et sur des compositions les contenant. La présente invention porte également sur un procédé pour la préparation desdits nouveaux composés ci-dessus et de leurs dérivés, stéréoisomères et sels pharmaceutiquement acceptables. Les composés de formule générale (I) sont utiles dans le traitement de divers troubles liés aux récepteurs nicotiniques a4ß2.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2785957C |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ALPHA.4.BETA.2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A48%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KANDIKERE,%20NAGARAJ%20VISHWOTTAM&rft.date=2015-06-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2785957C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |